SBFM Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	31.81M
Średni wolumen	1.64M
Kapitalizacja rynkowa	944 803
EPS	$0 ( 2024-04-02 )
Następna data zysków	( $-8.00 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0.0130 (1.38%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-04	Slilaty Steve N.	Buy	100 000	Series B Preferred Stock
2024-02-08	Slilaty Steve N.	Buy	20 000	Series B Preferred Stock
2024-01-26	Beaudoin Marc	Buy	0
2022-11-30	Sebaaly Camille	Buy	30 000	Common Stock
2022-10-20	Chamoun Malek	Sell	0	Common Stock, par value $0.001 per share

INSIDER POWER
100.00
Last 67 transactions
Buy: 1 074 426 098 \| Sell: 315 420 609

Wolumen Korelacja

Długi: 0.19 (neutral)

Krótki: 0.90 (strong)

Signal:(34.554) Same movement expected

Sunshine Biopharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sunshine Biopharma, Inc. Korelacja - Waluta/Towar

0.79
( moderate )

0.70
( moderate )

0.00
( neutral )

0.72
( moderate )

0.00
( neutral )

0.25
( neutral )

Sunshine Biopharma, Inc. Finanse

Annual	2023
Przychody:	$24.09M
Zysk brutto:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2023
Przychody:	$24.09M
Zysk brutto:	$8.19M (33.99 %)
EPS:	$-0.190

FY	2022
Przychody:	$4.35M
Zysk brutto:	$1.70M (39.04 %)
EPS:	$-1.760

FY	2021
Przychody:	$228 426
Zysk brutto:	$110 596 (48.42 %)
EPS:	$-0.0609

Financial Reports:

No articles found.

Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatment compound. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. The company has a license agreement with the University of Georgia to advance the development of its anti-coronavirus lead compound, SBFM-PL4. Sunshine Biopharma, Inc. is headquartered in Pointe-Claire, Canada.